Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.

Leccia F, Del Vecchio L, Mariotti E, Di Noto R, Morel AP, Puisieux A, Salvatore F, Ansieau S.

Mol Cancer. 2014 Sep 12;13:213. doi: 10.1186/1476-4598-13-213.

2.

The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family.

Ruotolo A, Di Taranto MD, D'Agostino MN, Marotta G, Gentile M, Nunziata M, Sodano M, Di Noto R, Del Vecchio L, Rubba P, Fortunato G.

Clin Chem Lab Med. 2014 Aug;52(8):e175-8. doi: 10.1515/cclm-2014-0144. No abstract available.

PMID:
24607922
3.

Surface proteomic analysis of differentiated versus stem-like osteosarcoma human cells.

Gemei M, Corbo C, D'Alessio F, Di Noto R, Vento R, Del Vecchio L.

Proteomics. 2013 Nov;13(22):3293-7. doi: 10.1002/pmic.201300170. Epub 2013 Oct 9.

PMID:
24106197
4.

Characterization and predicted role of the microRNA expression profile in amnion from obese pregnant women.

Nardelli C, Iaffaldano L, Ferrigno M, Labruna G, Maruotti GM, Quaglia F, Capobianco V, Di Noto R, Del Vecchio L, Martinelli P, Pastore L, Sacchetti L.

Int J Obes (Lond). 2014 Mar;38(3):466-9. doi: 10.1038/ijo.2013.121. Epub 2013 Jul 2.

PMID:
23817051
5.

The secretome signature of colon cancer cell lines.

Imperlini E, Colavita I, Caterino M, Mirabelli P, Pagnozzi D, Del Vecchio L, Di Noto R, Ruoppolo M, Orrù S.

J Cell Biochem. 2013 Nov;114(11):2577-87. doi: 10.1002/jcb.24600.

PMID:
23744648
6.

Cytometric profiling of CD133+ cells in human colon 
carcinoma cell lines identifies a common core phenotype 
and cell type-specific mosaics.

Gemei M, Di Noto R, Mirabelli P, Del Vecchio L.

Int J Biol Markers. 2013 Sep 27;28(3):267-73. doi: 10.5301/JBM.5000020.

PMID:
23709346
7.

High aminopeptidase N/CD13 levels characterize human amniotic mesenchymal stem cells and drive their increased adipogenic potential in obese women.

Iaffaldano L, Nardelli C, Raia M, Mariotti E, Ferrigno M, Quaglia F, Labruna G, Capobianco V, Capone A, Maruotti GM, Pastore L, Di Noto R, Martinelli P, Sacchetti L, Del Vecchio L.

Stem Cells Dev. 2013 Aug 15;22(16):2287-97. doi: 10.1089/scd.2012.0499. Epub 2013 Apr 23.

8.

Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines.

Scudiero O, Galdiero S, Nigro E, Del Vecchio L, Di Noto R, Cantisani M, Colavita I, Galdiero M, Cassiman JJ, Daniele A, Pedone C, Salvatore F.

Antimicrob Agents Chemother. 2013 Apr;57(4):1701-8. doi: 10.1128/AAC.00934-12. Epub 2013 Jan 28.

9.

Diagnostic strategies to investigate cerebrospinal fluid involvement in haematological malignancies.

Galati D, Di Noto R, Del Vecchio L.

Leuk Res. 2013 Mar;37(3):231-7. doi: 10.1016/j.leukres.2012.11.016. Epub 2013 Jan 1. Review.

PMID:
23287431
10.

CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo.

Gemei M, Mirabelli P, Di Noto R, Corbo C, Iaccarino A, Zamboli A, Troncone G, Galizia G, Lieto E, Del Vecchio L, Salvatore F.

Cancer. 2013 Feb 15;119(4):729-38. doi: 10.1002/cncr.27794. Epub 2012 Oct 1.

11.

ImageStream promyelocytic leukemia protein immunolocalization: in search of promyelocytic leukemia cells.

Mirabelli P, Scalia G, Pascariello C, D'Alessio F, Mariotti E, Di Noto R, George TC, Kong R, Venkatachalam V, Basiji D, Del Vecchio L.

Cytometry A. 2012 Mar;81(3):232-7. doi: 10.1002/cyto.a.22013. Epub 2012 Jan 20.

12.

Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer.

Galizia G, Gemei M, Del Vecchio L, Zamboli A, Di Noto R, Mirabelli P, Salvatore F, Castellano P, Orditura M, De Vita F, Pinto M, Pignatelli C, Lieto E.

Arch Surg. 2012 Jan;147(1):18-24. doi: 10.1001/archsurg.2011.795.

PMID:
22250106
13.

Mollicutes contamination: a new strategy for an effective rescue of cancer cell lines.

Mariotti E, D'Alessio F, Mirabelli P, Di Noto R, Fortunato G, Del Vecchio L.

Biologicals. 2012 Jan;40(1):88-91. doi: 10.1016/j.biologicals.2011.10.006. Epub 2011 Nov 9.

PMID:
22078664
14.

An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations.

Romano M, Di Taranto MD, Mirabelli P, D'Agostino MN, Iannuzzi A, Marotta G, Gentile M, Raia M, Di Noto R, Del Vecchio L, Rubba P, Fortunato G.

J Lipid Res. 2011 Nov;52(11):2095-100. doi: 10.1194/jlr.D017772. Epub 2011 Aug 24.

15.

Solid-phase synthesis and pharmacological evaluation of novel nucleoside-tethered dinuclear platinum(II) complexes.

D'Errico S, Oliviero G, Piccialli V, Amato J, Borbone N, D'Atri V, D'Alessio F, Di Noto R, Ruffo F, Salvatore F, Piccialli G.

Bioorg Med Chem Lett. 2011 Oct 1;21(19):5835-8. doi: 10.1016/j.bmcl.2011.07.104. Epub 2011 Aug 3.

PMID:
21855340
16.

Miniaturized flow cytometry-based BCR-ABL immunoassay in detecting leptomeningeal disease.

D'Alessio F, Mirabelli P, Mariotti E, Raia M, Di Noto R, Fortunato G, Camera A, Del Vecchio L.

Leuk Res. 2011 Oct;35(10):1290-3. doi: 10.1016/j.leukres.2011.05.016. Epub 2011 Jun 11.

PMID:
21658767
17.

Polychromatic flow cytometry analysis of CD34+ hematopoietic stem cells in cryopreserved early preterm human cord blood samples.

D'Alessio F, Mirabelli P, Gorrese M, Scalia G, Gemei M, Mariotti E, Di Noto R, Martinelli P, Fortunato G, Paladini D, Del Vecchio L.

Cytometry A. 2011 Jan;79(1):14-24. doi: 10.1002/cyto.a.20989.

18.

Divergent expression of CD133 in different studies on HCT-116 cell line.

Gemei M, Mirabelli P, Di Noto R, Fortunato G, Del Vecchio L.

Int J Cancer. 2011 Feb 15;128(4):998-1000. doi: 10.1002/ijc.25406. No abstract available.

19.

The percentage of CD133+ cells in human colorectal cancer cell lines is influenced by Mycoplasma hyorhinis infection.

Mariotti E, Gemei M, Mirabelli P, D'Alessio F, Di Noto R, Fortunato G, Del Vecchio L.

BMC Cancer. 2010 Mar 30;10:120. doi: 10.1186/1471-2407-10-120.

20.

Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity.

Scudiero O, Galdiero S, Cantisani M, Di Noto R, Vitiello M, Galdiero M, Naclerio G, Cassiman JJ, Pedone C, Castaldo G, Salvatore F.

Antimicrob Agents Chemother. 2010 Jun;54(6):2312-22. doi: 10.1128/AAC.01550-09. Epub 2010 Mar 22.

21.

Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy.

Romano M, Di Taranto MD, D'Agostino MN, Marotta G, Gentile M, Abate G, Mirabelli P, Di Noto R, Del Vecchio L, Rubba P, Fortunato G.

Atherosclerosis. 2010 Jun;210(2):493-6. doi: 10.1016/j.atherosclerosis.2009.11.051. Epub 2009 Dec 5.

PMID:
20045108
22.

Nanon effects on mammalian cell long-term cultures: a caveat for experimental hematologists dealing with in vitro long-term culture assays.

Mirabelli P, D'Alessio F, Mariotti E, Romano M, Fortunato G, Gemei M, Di Noto R, Del Vecchio L.

Exp Hematol. 2009 Aug;37(8):887-8. doi: 10.1016/j.exphem.2009.05.013. Epub 2009 Jun 12. No abstract available.

PMID:
19524638
23.

CD200/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells.

Brunetti L, Di Noto R, Abate G, Gorrese M, Gravetti A, Raia M, Scalia G, Pascariello C, Camera A, Del Vecchio L.

Br J Haematol. 2009 Jun;145(5):665-7. doi: 10.1111/j.1365-2141.2009.07644.x. Epub 2009 Mar 12. No abstract available.

PMID:
19344398
24.

Culture conditions allow selection of different mesenchymal progenitors from adult mouse bone marrow.

Esposito MT, Di Noto R, Mirabelli P, Gorrese M, Parisi S, Montanaro D, Del Vecchio L, Pastore L.

Tissue Eng Part A. 2009 Sep;15(9):2525-36. doi: 10.1089/ten.tea.2008.0509.

PMID:
19298168
25.

Functional characterization of ryanodine receptor (RYR1) sequence variants using a metabolic assay in immortalized B-lymphocytes.

Zullo A, Klingler W, De Sarno C, Ferrara M, Fortunato G, Perrotta G, Gravino E, Di Noto R, Lehmann-Horn F, Melzer W, Salvatore F, Carsana A.

Hum Mutat. 2009 Apr;30(4):E575-90. doi: 10.1002/humu.20991.

PMID:
19191333
26.

Comparative characteristics of mesenchymal stem cells from human bone marrow and placenta: CD10, CD49d, and CD56 make a difference.

Mariotti E, Mirabelli P, Abate G, Schiattarella M, Martinelli P, Fortunato G, Di Noto R, Del Vecchio L.

Stem Cells Dev. 2008 Dec;17(6):1039-41. doi: 10.1089/scd.2008.0212. No abstract available.

PMID:
18713024
27.

Extended flow cytometry characterization of normal bone marrow progenitor cells by simultaneous detection of aldehyde dehydrogenase and early hematopoietic antigens: implication for erythroid differentiation studies.

Mirabelli P, Di Noto R, Lo Pardo C, Morabito P, Abate G, Gorrese M, Raia M, Pascariello C, Scalia G, Gemei M, Mariotti E, Del Vecchio L.

BMC Physiol. 2008 May 29;8:13. doi: 10.1186/1472-6793-8-13.

28.

Critical role of multidimensional flow cytometry in detecting occult leptomeningeal disease in newly diagnosed aggressive B-cell lymphomas.

Di Noto R, Scalia G, Abate G, Gorrese M, Pascariello C, Raia M, Morabito P, Capone F, Pardo CL, Mirabelli P, Mariotti E, Del Vecchio L.

Leuk Res. 2008 Aug;32(8):1196-9. doi: 10.1016/j.leukres.2007.12.016. Epub 2008 Feb 11.

PMID:
18262645
29.

Rapid detection of mycoplasma in continuous cell lines using a selective biochemical test.

Mariotti E, Mirabelli P, Di Noto R, Fortunato G, Salvatore F.

Leuk Res. 2008 Feb;32(2):323-6. Epub 2007 Jun 21.

PMID:
17586045
30.

Flow cytometry analysis of acute promyelocytic leukemia: the power of 'surface hematology'.

Di Noto R, Mirabelli P, Del Vecchio L.

Leukemia. 2007 Jan;21(1):4-8. Review. No abstract available.

PMID:
17167527
31.

CMRL-T, a novel T-cell line showing asynchronous phenotype (CD34(+)/CD1a(-)/TCRalphabeta(+)) and dual T-cell receptor beta chain.

Di Noto R, Mirabelli P, Mariotti E, Sacchetti L, Pane F, Rotoli B, Lo Pardo C, Del Vecchio L, Mecucci C, Salvatore F.

Leukemia. 2006 Dec;20(12):2175-7. Epub 2006 Oct 26. No abstract available.

PMID:
17066091
32.

Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma.

Di Noto R, Pane F, Camera A, Luciano L, Barone M, Lo Pardo C, Boccuni P, Intrieri M, Izzo B, Villa MR, Macrí M, Rotoli B, Sacchetti L, Salvatore F, Del Vecchio L.

Leukemia. 2001 Oct;15(10):1641-9.

PMID:
11587224
33.

Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+) and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+) lymphoma/leukemia.

Camera A, Pezzullo L, Villa MR, Luciano L, Pane F, Izzo B, Boccuni P, Di Noto R, Del Vecchio L, Salvatore F, Rotoli B.

Haematologica. 2000 May;85(5):496-501.

34.

CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy.

Ferrara F, Morabito F, Martino B, Specchia G, Liso V, Nobile F, Boccuni P, Di Noto R, Pane F, Annunziata M, Schiavone EM, De Simone M, Guglielmi C, Del Vecchio L, Lo Coco F.

J Clin Oncol. 2000 Mar;18(6):1295-300.

PMID:
10715300
35.

Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria.

Boccuni P, Del Vecchio L, Di Noto R, Rotoli B.

Crit Rev Oncol Hematol. 2000 Jan;33(1):25-43. Review.

PMID:
10714960
36.

In vitro exposure of acute promyelocytic leukemia cells to arsenic trioxide (As2O3) induces the solitary expression of CD66c (NCA-50/90), a member of the CEA family.

Di Noto R, Boccuni P, Costantini S, Dello Russo A, Lo Pardo C, Copia C, Annunziata M, Cimino R, Ferrara F, Del Vecchio L.

Tissue Antigens. 1999 Dec;54(6):597-602.

PMID:
10674975
37.

Complete remission in acute myeloid leukaemia with t(8;21) following treatment with G-CSF: flow cytometric analysis of in vivo and in vitro effects on cell maturation.

Ferrara F, Di Noto R, Viola A, Russo C, Boccuni P, Costantini S, Dello Russo A, Lo Pardo C, Del Vecchio L.

Br J Haematol. 1999 Aug;106(2):520-3.

PMID:
10460615
38.

Complete remission of refractory anemia following a single high dose of cyclophosphamide.

Ferrara F, Copia C, Annunziata M, di Noto R, Russo C, Palmieri S, Spasiano A, del Vecchio L.

Ann Hematol. 1999 Feb;78(2):87-8.

PMID:
10089024
39.

CD66c antigen expression is myeloid restricted in normal bone marrow but is a common feature of CD10+ early-B-cell malignancies.

Boccuni P, Di Noto R, Lo Pardo C, Villa MR, Ferrara F, Rotoli B, Del Vecchio L.

Tissue Antigens. 1998 Jul;52(1):1-8.

PMID:
9714468
40.

Immunophenotypic analysis enables the correct prediction of t(8;21) in acute myeloid leukaemia.

Ferrara F, Di Noto R, Annunziata M, Copia C, Lo Pardo C, Boccuni P, Sebastio L, Del Vecchio L.

Br J Haematol. 1998 Jul;102(2):444-8.

PMID:
9695958
41.

Spontaneous splenic rupture in a patient with acute lymphoblastic leukemia of Burkitt type.

Ferrara F, D'Ambrosio V, Di Noto R, Mele G, Giovine S, Romano L.

Leuk Lymphoma. 1998 May;29(5-6):613-6.

PMID:
9643575
42.

JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesis.

Di Noto R, Luciano L, Lo Pardo C, Ferrara F, Frigeri F, Mercuro O, Lombardi ML, Pane F, Vacca C, Manzo C, Salvatore F, Rotoli B, Del Vecchio L.

Leukemia. 1997 Sep;11(9):1554-64.

PMID:
9305612
43.

Interstitial 9q deletion is associated with CD7+ acute leukemia of myeloid and T lymphoid lineage.

Ferrara F, Scognamiglio M, Di Noto R, Schiavone EM, Poggi V, Fiorillo A, Libertini R, Vicari L, Del Vecchio L, Sebastio L.

Leukemia. 1996 Dec;10(12):1990-2.

PMID:
8946942
44.

Immunological classification of acute leukemias: comments on the EGIL proposals.

Del Vecchio L, Di Noto R, Lo Pardo C, Schiavone EM, Vacca C, Ferrara F, Rotoli B.

Leukemia. 1996 Nov;10(11):1832-3. No abstract available.

PMID:
8892689
45.

Differential regulation of GPI-linked molecules on leukaemic promyelocytes treated in vitro with all-trans retinoic acid.

Di Noto R, Schiavone EM, Lo Pardo C, Ferrara F, Manzo C, Vacca C, Del Vecchio L.

Br J Haematol. 1996 May;93(2):392-3.

PMID:
8639434
46.

All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia.

Di Noto R, Lo Pardo C, Schiavone EM, Ferrara F, Manzo C, Vacca C, Del Vecchio L.

Leuk Lymphoma. 1996 Apr;21(3-4):201-9. Review.

PMID:
8726400
47.
48.
49.

Trisomy 13 in a case of myelofibrosis with myeloid metaplasia with early blastic transformation.

Ferrara F, Vicari L, Festa B, Di Noto R, Pane F, Sebastio L, Cimino R.

Haematologica. 1995 Sep-Oct;80(5):434-6.

50.

Simultaneous occurrence of tetrasomy 21 and trisomy 8 in a patient with early blastic metamorphosis of chronic myeloproliferative disorder.

Sebastio L, Ferrara F, Vicari L, di Noto R, del Vecchio L, Pane F, Fasanaro A, Cimino R, Salvatore F, Ventruto V.

Am J Hematol. 1995 Sep;50(1):49-52.

PMID:
7668224

Supplemental Content

Loading ...
Support Center